Wednesday, 18 July 2012

Abbott Labs earnings roughly in line with Wall St view



(Reuters) - Abbott Laboratories Inc reported quarterly earnings roughly in line with Wall Street expectations, helped by strong demand for its Humira arthritis drug and its Xience heart stent.





via Reuters: Health News Read More Here..

No comments:

Post a Comment